Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis

Gastroenterology

Volumn 114, Issue 1, 1998, Pages 15-22

  Green, J R B ^a   Lobo, A J ^a   Holdsworth, C D ^a   Leicester, R J ^a   Gibson, J A ^a   Kerr, G D ^a   Hodgson, H J F ^a   Parkins, K J ^a   Taylor, M D ^a   Brown, P ^a   Cann, P ^a   Barrison, I G ^a   Bell, G D ^a   Willoughby, C P ^a   Wheeler, P ^a   Swarbrick, E T ^a   Grainger, S L ^a   Isaacs, P ^a   Shaffer, J L ^a   Howard, P ^a   Willoughby, J M ^a   Goodman, M J ^a   Bramble, M G ^a   Dickinson, R J ^a   Arthur, M J P ^a   more..

^a CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BALSALAZIDE; HYDROCORTISONE ACETATE; MESALAZINE; PLACEBO; PRODRUG; STEROID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SIGMOIDOSCOPY; TABLET; ULCERATIVE COLITIS; UNITED KINGDOM;

EID: 6844237647     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70627-4     Document Type: Article

References (25)

1. JF Mayberr y Some aspects of the epidemiology of ulcerative colitis Gut 26 1985 968 974
2. JMD Nightingale BJ Rathbone Inflammatory bowel disease Update 17 1996 13 24
3. MA Kamm A Senapati Drug management of ulcerative colitis Br Med J 305 1992 35 38
4. B Crotty D Jewell Drug therapy of ulcerative colitis Br J Clin Pharmacol 34 1992 189 198
5. JH Baron AM Connell JE Lennard-Jones F Avery Jones Sulphasalazine and salicylazosulphadimidine in ulcerative colitis Lancet 1 1962 1094 1096
6. JJ Misiewicz JE Lennard-Jones AM Connell JH Baron F Avery Jones Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis Lancet 1 1965 185 188
7. SL Taffet KM Das Sulfasalazine. Adverse effects and desensitisation Dig Dis Sci 28 1983 833 842
8. JC Mansfield MH Giaffer PA Cann CD Holdsworth PC Thornton Is high dose balsalazide (BSZ) better than sulphasalazine (SASP) in initial management of ulcerative colitis (UC) (abstr) Gut 32 1991 A1217
9. JRB Green CHJ Swan AE Rowlinson JA Gibson P Brown GD Kerr ET Swarbrick PC Thornton Sulphasalazine or high dose balsalazide to treat acute relapse in ulcerative colitis? Results of a randomised trial (abstr) Gastroenterology 104 Suppl 1993 A709
10. PB McIntyre JE Lennard-Jones Reversal with balsalazide of infertility caused by sulphasalazine Br Med J 288 1984 1652 1653
11. KM Das MA Eastwood JPA McManus W Sircus Adverse reactions during salicylazosulphapyridine therapy and the relation with drug metabolism and acetylator phenotype N Engl J Med 289 1973 491 495
12. AK Azad Khan J Piris SC Truelove An experiment to determine the active therapeutic moiety of sulphasalazine Lancet 2 1977 892 895
13. MJ Dew PJ Hughes MG Lee BK Evans J Rhodes An oral preparation to release drugs in the human colon Br J Clin Pharmacol 14 1982 405 408
14. JRB Green The treatment of ulcerative colitis with balsalazide sodium Inflammopharmacology 2 1993 289 295
15. PB McIntyre CA Rodrigues JE Lennard-Jones IG Barrison JG Walker JH Baron P Thornton Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine Aliment Pharmacol Ther 2 1988 237 243
16. JRB Green CH Swan A Rowlinson JA Gibson P Brown GD Kerr ET Swarbrick P Thornton Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months Aliment Pharmacol Ther 6 1992 647 652
17. MH Giaffer CJ O'Brien CD Holdsworth Clinical tolerance to three 5-amino salicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine Aliment Pharmacol Ther 6 1992 51 59
18. SA Riley V Mani MJ Goodman ME Herd S Dutt LA Turnberg Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse Gut 29 1988 669 674
19. SA Riley V Mani MJ Goodman ME Herd S Dutt LA Turnberg Comparison of delayed-release 5 aminosalicylic acid (mesalazine) and sulphasalazine as maintenance treatment for patients with ulcerative colitis Gastroenterology 94 1988 1383 1389
20. MJ Dew AD Harries BK Evans J Rhodes Treatment of ulcerative colitis with oral 5–aminosalicylic acid in patients unable to take SASP (letter) Lancet 2 1983 801
21. Committee on Safety of Medicines Curr Probl 30 1990
22. CA Sninsky DH Cort F Shanahan BJ Powers JT Sessions RE Pruitt WH Jacobs SK Lo SR Targan JJ Cerda DE Gremillon WJ Snape J Sabel H Jinich JM Swinehart MP DeMicco Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis—a multicenter study Ann Intern Med 115 1991 350 355
23. SB Hanauer J Schwartz M Robinson Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial Am J Gastroenterol 88 1993 1188 1197
24. SB Hanauer Topical and oral aminosalicylates M Peppercorn The management of inflammatory bowel disease: new medical surgical approaches 1990 Dekker New York 65 91
25. SB Hanauer Medical therapy of ulcerative colitis Lancet 342 1993 412 417